Incidence of Venous Thromboembolism by Type of Gynecologic Malignancy and Surgical Modality in the National Surgical Quality Improvement Program

International Journal of Gynecological Cancer

Volumn 27, Issue 3, 2017, Pages 581-587

  Graul, Ashley ^a   Latif, Nawar ^a   Zhang, Xiaochen ^b   Dean, Lorraine T ^c   Morgan, Mark ^a   Giuntoli, Robert ^a   Burger, Robert ^a   Kim, Sarah ^a   Ko, Emily ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Gynecologic oncology; NSQIP; Venous thromboembolism

Indexed keywords

CANCER PATIENT; CANCER RISK; CANCER SURGERY; CONFERENCE PAPER; DATA BASE; DEEP VEIN THROMBOSIS; FEMALE; FEMALE GENITAL TRACT CANCER; GYNECOLOGIC SURGERY; HUMAN; INCIDENCE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MINIMALLY INVASIVE SURGERY; OVARY CANCER; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TOTAL QUALITY MANAGEMENT; UTERINE CERVIX CANCER; UTERUS CANCER; VENOUS THROMBOEMBOLISM; VULVA CANCER; ADULT; AGED; BLOOD; COHORT ANALYSIS; FACTUAL DATABASE; FEMALE GENITAL TRACT TUMOR; MIDDLE AGED; OVARY TUMOR; PATHOLOGY; STATISTICS AND NUMERICAL DATA; UNITED STATES;

ADULT; AGED; COHORT STUDIES; DATABASES, FACTUAL; FEMALE; GENITAL NEOPLASMS, FEMALE; GYNECOLOGIC SURGICAL PROCEDURES; HUMANS; INCIDENCE; MIDDLE AGED; OVARIAN NEOPLASMS; UNITED STATES; VENOUS THROMBOEMBOLISM;

EID: 85014567545     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0000000000000912     Document Type: Conference Paper

References (25)

1. Center for Disease Control. Data and Statistics. DVT/PE. NCBDDD. Available at: http://www.cdc.gov/ncbddd/dvt/data. html. Accessed August 25 2015.
2. Osborne NH, Wakefield TW, Henke PK. Venous thromboembolism in cancer patients undergoing major surgery. Ann Surg Oncol. 2008;15:3567-3578.
3. Behranwala KA, Williamson RC. Cancer-associated venous thrombosis in the surgical setting. Ann Surg. 2009;249: 366-375.
4. López JA, Chen J. Pathophysiology of venous thrombosis. Thromb Res. 2009;123(suppl 4):S30-S34.
5. Kessler CM. The link between cancer and venous thromboembolism: a review. Am J Clin Oncol. 2009; 32(suppl 4):S3-S7.
6. Tateo S, Mereu L, Salamano S, et al. Ovarian cancer and venous thromboembolic risk. Gynecol Oncol. 2005;99:119-125.
7. Peedicayil A, Weaver A, Li X, et al. Incidence and timing of venous thromboembolism after surgery for gynecological cancer. Gynecol Oncol. 2011;121:64-69.
8. Key NS, Khorana AA, Mackman N, et al. Thrombosis in cancer: research priorities identified by a National Cancer Institute/National Heart, Lung, and Blood Institute Strategic Working Group. Cancer Res. 2016;76:3671-3675.
9. American College of Surgeons. User Guide for the 2015 ACS NSQIP Participant Use Data File. 2015;1-41.
10. Heit JA, Silverstein MD, Mohr DN, et al. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med. 2000;160:809-815.
11. Lyman GH, Khorana AA, Falanga A, et al. American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer. J Clin Oncol. 2007;25:5490-5505.
12. Streiff MB. The National Comprehensive Cancer Center Network (NCCN) guidelines on the management of venous thromboembolism in cancer patients. Thromb Res. 2010;125 (suppl 2):S128-S133.
13. Bergqvist D, Burmark US, Flordal PA, et al. Low molecular weight heparin started before surgery as prophylaxis against deep vein thrombosis: 2500 versus 5000 XaI units in 2070 patients. Br J Surg. 1995;82:496-501.
14. Rasmussen MS, Jorgensen LN, Wille-Jørgensen P, et al. Prolonged prophylaxis with dalteparin to prevent late thromboembolic complications in patients undergoing major abdominal surgery: a multicenter randomized open-label study. J Thromb Haemost. 2006;4:2384-2390.
15. Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest. 2008;133(suppl 6):S381-S453.
16. Correction to dosage in: Executive Summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed. American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141:1129.
17. Levitan N, Dowlati A, Remick SC, et al. Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data. Medicine (Baltimore). 1999;78:285-291.
18. Rodriguez AO, Wun T, Chew H, et al. Venous thromboembolism in ovarian cancer. Gynecol Oncol. 2007;105:784-790.
19. Wun T, White RH. Venous thromboembolism (VTE) in patients with cancer: epidemiology and risk factors. Cancer Invest. 2009;27(suppl 1):63-74.
20. Morimoto A, Ueda Y, Yokoi T, et al. Perioperative venous thromboembolism in patients with gynecological malignancies: a lesson from four years of recent clinical experience. Anticancer Res. 2014;34:3589-3595.
21. Santoso JT, Evans L, Lambrecht L, et al. Deep venous thrombosis in gynecological oncology: incidence and clinical symptoms study. Eur J Obstet Gynecol Reprod Biol. 2009;144:173-176.
22. Bouchard-Fortier G, Geerts WH, Covens A, et al. Is venous thromboprophylaxis necessary in patients undergoing minimally invasive surgery for a gynecologic malignancy? Gynecol Oncol. 2014;134:228-232.
23. Nick AM, Schmeler KM, Frumovitz MM, et al. Risk of thromboembolic disease in patients undergoing laparoscopic gynecologic surgery. Obstet Gynecol. 2010;116:956-961.
24. Kumar S, Al-Wahab Z, Sarangi S, et al. Risk of postoperative venous thromboembolism after minimally invasive surgery for endometrial and cervical cancer is low: a multi-institutional study. Gynecol Oncol. 2013;130:207-212.
25. Sandadi S, Lee S, Walter A, et al. Incidence of venous thromboembolism after minimally invasive surgery in patients with newly diagnosed endometrial cancer. Obstet Gynecol. 2012;120:1077-1083.